# Utility of PCD Diagnostics to Improve Clinical Care

> **NCT05889013** · — · RECRUITING · sponsor: **Connecticut Children's Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Primary Ciliary Dyskinesia

## Interventions

- **DEVICE:** Nasal Nitric Oxide testing

## Key facts

- **NCT ID:** NCT05889013
- **Lead sponsor:** Connecticut Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-17
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05889013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05889013, "Utility of PCD Diagnostics to Improve Clinical Care". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05889013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*